𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glycomic analysis by capillary electrophoresis–mass spectrometry

✍ Scribed by Yehia Mechref; Milos V. Novotny


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
477 KB
Volume
28
Category
Article
ISSN
0277-7037

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The occurrence of multiple glycosylation sites on a protein, together with the number of glycan structures which could potentially be associated with each site (microheterogeneity) often leads to a large number of structural combinations. These structural variations increase with the molecular size of a protein, thus contributing to the complexity of glycosylation patterns. Resolving such fine structural differences has been instrumentally difficult. The degree of glycoprotein microheterogeneity has been analytically challenging in the identification of unique glycan structures that can be crucial to a distinct biological function. Despite the wealth of information provided by the most powerful mass spectrometric (MS) and tandem MS techniques, they are not able to readily identify isomeric structures. Although various separation methods provide alternatives for the analysis of glycan pools containing isomeric structures, capillary electrophoresis (CE) is often the method of choice for resolving closely related glycan structures because of its unmatched separation efficiency. It is thus natural to consider combining CE with the MS‐based technologies. This review describes the utility of different CE approaches in the structural characterization of glycoproteins, and discusses the feasibility of their interface to mass spectrometry. © 2009 Wiley Periodicals, Inc., Mass Spec Rev 28:207–222, 2009


📜 SIMILAR VOLUMES


Analysis of Reduced and Oxidized Forms o
✍ Tao He; Nagarajan Chandramouli; Emil Fu; Arthur Wu; Y.Karen Wang 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 64 KB

transgene product in the circulation is promising with respect to the levels that must be achieved for some therapeutic genes. For example, the range of circulating level of human growth hormone in healthy children is between 1 and 10 ng/ml (11). Phenotypic correction of hemophilia could be obtained